Cargando…

Safety and Short-term Outcomes of High-Dose Erythropoietin in Preterm Infants With Intraventricular Hemorrhage: The EpoRepair Randomized Clinical Trial

IMPORTANCE: Intraventricular hemorrhage (IVH) is a major cause of neonatal morbidity and mortality in preterm infants without a specific medical treatment to date. OBJECTIVE: To assess the safety and short-term outcomes of high-dose erythropoietin in preterm infants with IVH. DESIGN, SETTING, AND PA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wellmann, Sven, Hagmann, Cornelia F., von Felten, Stefanie, Held, Leonard, Klebermass-Schrehof, Katrin, Truttmann, Anita C., Knöpfli, Claudia, Fauchère, Jean-Claude, Bührer, Christoph, Bucher, Hans Ulrich, Rüegger, Christoph M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2022
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719050/ https://www.ncbi.nlm.nih.gov/pubmed/36459138 http://dx.doi.org/10.1001/jamanetworkopen.2022.44744

Ejemplares similares

Long-term neuroprotective effect of erythropoietin on executive functions in very preterm children (EpoKids): protocol of a prospective follow-up study
por: Wehrle, Flavia Maria, et al.
Publicado: (2018)

Effect of Early High-Dose Recombinant Human Erythropoietin on Behavior and Quality of Life in Children Aged 5 Years Born Very Preterm: Secondary Analysis of a Randomized Clinical Trial
por: Picotti, Eleonora, et al.
Publicado: (2022)

Genetic variants of erythropoietin (EPO) and EPO receptor genes in familial erythrocytosis
por: Vočanec, Danijela, et al.
Publicado: (2018)

Erythropoietin (EPO) in acute kidney injury
por: Moore, Elizabeth, et al.
Publicado: (2011)

A novel magnetic resonance imaging‐based scoring system to predict outcome in neonates born preterm with intraventricular haemorrhage
por: Goeral, Katharina, et al.
Publicado: (2021)

Erythropoietin Improves Poor Outcomes in Preterm Infants with Intraventricular Hemorrhage
por: Song, Juan, et al.
Publicado: (2021)

Prophylactic Erythropoietin for Neuroprotection in Very Preterm Infants: A Meta-Analysis Update
por: Fischer, Hendrik S., et al.
Publicado: (2021)

Mental development is associated with cortical connectivity of the ventral and nonspecific thalamus of preterm newborns
por: Jakab, Andras, et al.
Publicado: (2020)

Case report: Intrapulmonary tidal volumes in a preterm infant with chest wall rigidity
por: Gaertner, Vincent D., et al.
Publicado: (2022)

Association between Fat-Free Mass and Brain Size in Extremely Preterm Infants
por: Binder, Christoph, et al.
Publicado: (2021)

Early life serum neurofilament dynamics predict neurodevelopmental outcome of preterm infants
por: Goeral, Katharina, et al.
Publicado: (2021)

Regulation of Erythropoietin Receptor Activity in Endothelial Cells by Different Erythropoietin (EPO) Derivatives: An in Vitro Study
por: Trincavelli, Maria Letizia, et al.
Publicado: (2013)

Comparison of Neurite Outgrowth Induced by Erythropoietin (EPO) and Carbamylated Erythropoietin (CEPO) in Hippocampal Neural Progenitor Cells
por: Oh, Dong Hoon, et al.
Publicado: (2012)

EPO does not promote interaction between the erythropoietin and beta-common receptors
por: Cheung Tung Shing, Karen S., et al.
Publicado: (2018)

Coping with hypoxemia: Could erythropoietin (EPO) be an adjuvant treatment of COVID-19?
por: Soliz, Jorge, et al.
Publicado: (2020)

Discrepancy between invasive and non-invasive blood pressure readings in extremely preterm infants in the first four weeks of life
por: Werther, Tobias, et al.
Publicado: (2018)

SyMRI detects delayed myelination in preterm neonates
por: Schmidbauer, Victor, et al.
Publicado: (2019)

The hypoxia inducible factor/erythropoietin (EPO)/EPO receptor pathway is disturbed in a rat model of chronic kidney disease related anemia
por: Landau, Daniel, et al.
Publicado: (2018)

Human recombinant erythropoietin (rEpo) has no effect on tumour growth or angiogenesis
por: Hardee, M E, et al.
Publicado: (2005)

Assessment of Comfort during Less Invasive Surfactant Administration in Very Preterm Infants: A Multicenter Study
por: Pichler, Karin, et al.
Publicado: (2023)

Erythropoietin (EPO)-receptor signaling induces cell death of primary myeloma cells in vitro
por: Våtsveen, Thea Kristin, et al.
Publicado: (2016)

Author Correction: EPO does not promote interaction between the erythropoietin and beta-common receptors
por: Cheung Tung Shing, Karen S., et al.
Publicado: (2019)

Population based trends in mortality, morbidity and treatment for very preterm- and very low birth weight infants over 12 years
por: Rüegger, Christoph, et al.
Publicado: (2012)

Regular lung recruitment maneuvers during high-frequency oscillatory ventilation in extremely preterm infants: a randomized controlled trial
por: Werther, Tobias, et al.
Publicado: (2022)

Structural Identification of Modified Amino Acids on the Interface between EPO and Its Receptor from EPO BRP, Human Recombinant Erythropoietin by LC/MS Analysis
por: Song, Kwang-Eun, et al.
Publicado: (2014)

Impact of a Multifactorial Educational Training on the Management of Preterm Infants in the Central-Eastern European Region
por: Steinbauer, Philipp, et al.
Publicado: (2021)

Network based statistics reveals trophic and neuroprotective effect of early high dose erythropoetin on brain connectivity in very preterm infants
por: Jakab, A., et al.
Publicado: (2019)

Reliability and accuracy of EEG interpretation for estimating age in preterm infants
por: Stevenson, Nathan J., et al.
Publicado: (2020)

Who Plays the Strings in Newborn Analgesia at Birth, Vasopressin or Oxytocin?
por: Wellmann, Sven, et al.
Publicado: (2012)

Functional maturation in preterm infants measured by serial recording of cortical activity
por: Stevenson, N. J., et al.
Publicado: (2017)

Erythropoietin Improves Atrophy, Bleeding and Cognition in the Newborn Intraventricular Hemorrhage
por: Hierro-Bujalance, Carmen, et al.
Publicado: (2020)

Huh-7 cell line as an alternative cultural model for the production of human like erythropoietin (EPO)
por: Kausar, Humera, et al.
Publicado: (2011)

Response Assessment to Erythropoietin-Zeta (Epo-Alpha Biosimilar) Therapy in Low-Risk Myelodysplastic Syndromes
por: Vetro, Calogero, et al.
Publicado: (2022)

Erythropoietin Receptor (EPOR) Signaling in the Osteoclast Lineage Contributes to EPO-Induced Bone Loss in Mice
por: Awida, Zamzam, et al.
Publicado: (2022)

Creative music therapy to promote brain function and brain structure in preterm infants: A randomized controlled pilot study
por: Haslbeck, Friederike Barbara, et al.
Publicado: (2020)

Intraventricular hemorrhage in preterm babies
por: Özek, Eren, et al.
Publicado: (2020)

Erythropoietin accelerates tumor growth through increase of erythropoietin receptor (EpoR) as well as by the stimulation of angiogenesis in DLD-1 and Ht-29 xenografts
por: Tankiewicz-Kwedlo, A., et al.
Publicado: (2016)

Post-mortem magnetic resonance imaging with computed tomography-guided biopsy for foetuses and infants: a prospective, multicentre, cross-sectional study
por: Rüegger, Christoph Martin, et al.
Publicado: (2022)

r.hu-Erythropoietin (EPO) treatment of pre-ESRD patients slows the rate of progression of renal decline
por: Tapolyai, Mihály, et al.
Publicado: (2003)

Comparative Study of Recombinant Human Erythropoietin (rhEPO) Products on CKD (Chronic Kidney Disease) Patients
por: Dwitanto, Kuspuji, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6u26ku8dsss2hus8pdhtaibglr